pRedF
(Plasmid
#118057)
-
PurposeGBPart - RedF Luciferase CDS
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 118057 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepUPD
-
Backbone manufacturerDiego Orzaez Lab
- Backbone size w/o insert (bp) 3057
- Total vector size (bp) 4705
-
Modifications to backboneAmpicillin Resistance
-
Vector typeSynthetic Biology ; Domestication of DNA parts for GoldenBraid asembly
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameRed Firefly Luciferase CDS
-
Alt nameRed mutant S286Y luciferase from Luciola curciata
-
SpeciesSynthetic; Luciola curciata
-
Insert Size (bp)1684
-
MutationRed mutant S286Y
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BsmBI (destroyed during cloning)
- 3′ cloning site BsmBI (destroyed during cloning)
- 5′ sequencing primer taatacgactcactatagg
- 3′ sequencing primer gtcatagctgtttcctg (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Insert can be released with BsaI
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pRedF was a gift from Koen Venken (Addgene plasmid # 118057 ; http://n2t.net/addgene:118057 ; RRID:Addgene_118057) -
For your References section:
Examining multiple cellular pathways at once using multiplex hextuple luciferase assaying. Sarrion-Perdigones A, Chang L, Gonzalez Y, Gallego-Flores T, Young DW, Venken KJT. Nat Commun. 2019 Dec 13;10(1):5710. doi: 10.1038/s41467-019-13651-y. 10.1038/s41467-019-13651-y PubMed 31836712